Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Cubist Pharmaceuticals pays $92.5M for Calixa
Yahoo/AP
Mon, 12/14/09 - 11:48 am
Cubist Pharmaceuticals
M&A
Calixa
Glaxo to Buy Stake in Intercell in Vaccines Alliance
Bloomberg
Fri, 12/11/09 - 10:29 am
Intercell
M&A
vaccines
GSK
Facet rejects Biogen Idec offer
Bizjournals.com
Thu, 12/10/09 - 10:30 am
Facet Biotech
M&A
Biogen Idec
How Gloucester Achieved the Impossible Even Before Inking the Celgene Deal
BNET Pharma
Thu, 12/10/09 - 10:27 am
Celgene
Glouchester Pharma
M&A
SEC eyes 9 deals in insider trading probe: report
Yahoo/Reuters
Thu, 12/10/09 - 08:45 am
Wyeth
SEC
Schering Plough
Pfizer
Merck
M&A
Eli Lilly
insider trading
Abbott Laboratories
Major Surgery at Sanofi
Businessweek
Thu, 12/10/09 - 08:35 am
Sanofi
Chris Viehbacher
Pharma CEOs
M&A
Watson Acquires Arrow
Yahoo/Zacks.com
Thu, 12/10/09 - 07:39 am
Watson Pharmaceuticals
Arrow
M&A
Sizzling market heats up biotech buyout fever
Fierce Biotech
Wed, 12/9/09 - 10:55 am
biotech
M&A
Merrimack Pharmaceuticals
Hermes
Celgene
Glouchester Pharma
Gloucester Pharma Proves Single-Drug Model Can Work
WSJ Online
Wed, 12/9/09 - 10:25 am
Glouchester Pharma
Celgene
M&A
Istodax
non-Hodgkin's lymphoma
Buyout Buzz at ASH Hematology Confab
Seeking Alpha
Mon, 12/7/09 - 07:44 pm
M&A
Allos
Celgene
Cyclacel
Seattle Genetics
Biogen Idec Blinks: Is It Enough for Facet Biotech, or Will the Drama Continue?
BNET Pharma
Mon, 12/7/09 - 12:49 pm
Facet Biotech
Biogen Idec
M&A
Celgene Buys Gloucester Pharma
TheStreet.com
Mon, 12/7/09 - 12:34 pm
Celgene
Glouchester Pharma
M&A
Facet Biotech Advises Stockholders to Take No Action in Response to Revised Biogen Idec Tender Offer
Yahoo
Thu, 12/3/09 - 07:29 pm
Biogen Idec
Facet Biotech
M&A
Biogen raises Facet offer to $17.50 per share
Yahoo/AP
Thu, 12/3/09 - 05:40 pm
Facet Biotech
Biogen Idec
M&A
Should Amgen Buy Human Genome Sciences?
Forbes
Thu, 12/3/09 - 05:39 pm
Human Genome Sciences
Amgen
M&A
No Holiday For Biopharma P & A
CNBC
Thu, 12/3/09 - 03:12 pm
partnerships
M&A
Pfizer
Protalix BioTherapeutics
Targacept
AstraZeneca
Merck
Amgen
GSK
Human Genome Sciences
Novartis buy seen likely after Alcon shares gain
Reuters
Thu, 12/3/09 - 11:22 am
Novartis
M&A
Alcon
Nestle
Sun gets Taro investor support for buyout
Fierce Pharma
Wed, 12/2/09 - 01:59 pm
Taro
Sun Pharma
M&A
Generics heat up: Cipla in talks with Big Pharma; Takeda mulls M&As
In-Pharma Technologist
Tue, 12/1/09 - 07:11 am
Cipla
Takeda
M&A
generics
GlaxoSmithKline takes 19 percent stake in South Africa's Aspen as it continues to diversify
Yahoo/AP
Tue, 12/1/09 - 06:47 am
Aspen
M&A
GSK
diversification
South Africa
Pages
« first
‹ previous
…
312
313
314
315
316
317
318
319
320
…
next ›
last »